Stomach Cancer Trial, Recruiting (NCT06105515)

Stomach Cancer Trial, Recruiting NCT06105515 Sponsor: Region Stockholm Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06105515 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with stomach cancer that has grown into the stomach wall or nearby tissues but has not spread to the lymph nodes or other parts of the body
Your stomach tumor falls into a specific shape/growth pattern category (called Borrmann type 1-2) and is smaller than 5 cm, OR it is another growth pattern (Borrmann type 3) and is smaller than 2 cm (confirm with trial site)
A team of specialists has reviewed your case and decided that surgery to remove the stomach (gastrectomy) is not a suitable option for you
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

Your tumor is classified as a specific spreading/diffuse type of stomach cancer (called Borrmann type 4, sometimes known as "linitis plastica") (confirm with trial site)
Your tumor is located at the top part of the stomach where it connects to the food pipe (an area called the cardia)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ioannis Rouvelas, MD, PhD, ME Övre buk, Karolinska Universitetssjukhuset

Phone: +46707976814

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06105515

Sponsor: Region Stockholm

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: +46707976814

More information: https://clinicaltrials.gov/study/NCT06105515

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with stomach cancer that has grown into the stomach wall or nearby tissues but has not spread to the lymph nodes or other parts of the body
Your stomach tumor falls into a specific shape/growth pattern category (called Borrmann type 1-2) and is smaller than 5 cm, OR it is another growth pattern (Borrmann type 3) and is smaller than 2 cm (confirm with trial site)
A team of specialists has reviewed your case and decided that surgery to remove the stomach (gastrectomy) is not a suitable option for you
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

Your tumor is classified as a specific spreading/diffuse type of stomach cancer (called Borrmann type 4, sometimes known as "linitis plastica") (confirm with trial site)
Your tumor is located at the top part of the stomach where it connects to the food pipe (an area called the cardia)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Region Stockholm

Registry

ClinicalTrials.gov

Start date

17 April 2024

Est. completion

1 December 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Severe complication

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov